It is worth noting that, although the authors demonstrated that SMYD3 physically interacted with the BCLAF1 promoter [48], it is possible that SMYD3 may regulate bladder cancer growth via AR, because of its previously reported interaction with the receptor [30]. The gene discussed is SMYD3; the disease is urinary bladder carcinoma.